U.S. Opportunities Fund
U.S. Opportunities Fund - Investor GBP Dist (VANGUOG)
Related Documents
Start a savings plan or make a one-off investment
Invest now with an online broker
Learn moreAbout this fund
Fund objectives
- The Fund seeks to provide long-term capital growth.
- The Fund employs an “active management” strategy to invest mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. The Fund’s Sub-Investment Manager, PRIMECAP Management Company (“PRIMECAP”), uses fundamental research to identify stocks that are expected to outperform the market over a three to five-year time horizon and that are available at attractive prices relative to their fundamental values. The Fund has the flexibility to invest in companies of any size, but it mostly invests in small and mid-cap stocks.
- The Fund may measure performance against the Russell 3000 Index (the “Index”), a market-capitalisation-weighted stock market index, composed of the top 3,000 US publically traded companies, as ranked by market capitalisation, or the total dollar value of all outstanding shares. The Fund is not otherwise constrained by or managed with reference to the Index. The Index does not define the investment universe of the Fund and the composition of the Fund may deviate significantly from that of the Index.
- The Fund’s policy is to remain substantially invested in common stocks that are listed or traded on exchanges or markets in the United States.
Fund facts
Share class inception
19 Dec 2006
Minimum initial investment
£100,000.00
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Strategy
Active
Asset Class
Equity
Domicile
Ireland
Dividend schedule
Annually
Legal entity
Vanguard Investment Series PLC
Tax status
Austria, Germany, Switzerland and United Kingdom reporting
Benchmark
Russell 3000 Index
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at 30 Sep 2026
Beta
R²
Annualized Tracking Error
1 year
3 years
5 years
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 211 | 2,996 | 30 Sep 2026 |
| Median market capital | 28.7 B | 278.8 B | 30 Sep 2026 |
| 24.0 x | 24.0 x | 30 Sep 2026 | |
| 4.7 x | 4.8 x | 30 Sep 2026 | |
| 13.1% | 26.3% | 30 Sep 2026 | |
| 19.3% | 23.5% | 30 Sep 2026 | |
| Portfolio turnover rate | 5.4% | — | 30 Sep 2026 |
Market allocation
As at 30 Sep 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United States of America | North America | 93.00% | 99.36% | -6.36% |
| China | Emerging Markets | 3.40% | — | — |
| United Kingdom | Europe | 1.47% | — | — |
| Canada | North America | 1.04% | — | — |
| Germany | Europe | 0.35% | — | — |
| Sweden | Europe | 0.31% | 0.12% | 0.19% |
| Switzerland | Europe | 0.21% | — | — |
| France | Europe | 0.13% | — | — |
| Japan | Pacific | 0.10% | — | — |
| Argentina | Emerging Markets | 0.00% | 0.00% | 0.00% |
| Brazil | Emerging Markets | 0.00% | 0.09% | -0.09% |
| Israel | Middle East | 0.00% | 0.00% | 0.00% |
| Other | Other | 0.00% | 0.40% | -0.40% |
| Panama | Emerging Markets | 0.00% | 0.00% | 0.00% |
| Peru | Emerging Markets | 0.00% | 0.03% | -0.03% |
Holdings details
As at 30 Sep 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| Micron Technology Inc | 9.58126% | Information Technology | US | £136,376,684.40 | 128,040 |
| Xometry Inc | 5.05424% | Industrials | US | £71,940,489.50 | 699,470 |
| Eli Lilly & Co | 3.92338% | Health Care | US | £55,844,152.04 | 48,263 |
| Flex Ltd | 3.89030% | Information Technology | US | £55,373,365.60 | 503,440 |
| Intel Corp | 3.01046% | Information Technology | US | £42,849,972.00 | 356,400 |
| GRAIL Inc | 2.50050% | Health Care | US | £35,591,320.72 | 254,006 |
| Alphabet Inc | 2.17079% | Communication Services | US | £30,898,384.00 | 89,800 |
| BeOne Medicines Ltd | 1.84424% | Health Care | US | £26,250,339.96 | 71,734 |
| Glaukos Corp | 1.70411% | Health Care | US | £24,255,788.70 | 147,730 |
| Nextpower Inc | 1.66731% | Industrials | US | £23,731,944.97 | 304,529 |
Prices and distribution
Prices
NAV Price (GBP)
£2,083.63
GBPChange
-£136.65-6.15% At closure 05 Nov 2026
NAV 52-week high
£2,410.70
At closure 06 Nov 2026
NAV 52-week low
£1,696.35
At closure 06 Nov 2026
NAV 52-week difference
£714.35
Change
+29.63% At closure 06 Nov 2026
Historical Prices
-
Inception date
19 Dec 2006
| Date | NAV (GBP) |
|---|---|
| 05 Nov 2026 | £2,083.6311 |
| 04 Nov 2026 | £2,220.2766 |
| 03 Nov 2026 | £2,204.8564 |
| 02 Nov 2026 | £2,174.0369 |
| 30 Oct 2026 | £2,188.3827 |
| 29 Oct 2026 | £2,264.5826 |
| 28 Oct 2026 | £2,267.1438 |
| 27 Oct 2026 | £2,230.3858 |
| 26 Oct 2026 | £2,178.1951 |
| 23 Oct 2026 | £2,146.6334 |
Distribution history
Distribution frequency
Annually
Historical performance 30 Sep 2026
0.42%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | £0.0000 | 31 Dec 2025 | 30 Dec 2025 | 15 Jan 2026 |
| Income | £0.0000 | 31 Dec 2024 | 30 Dec 2024 | 15 Jan 2025 |
| Income | £0.0000 | 29 Dec 2023 | 28 Dec 2023 | 15 Jan 2024 |
| Income | £0.0000 | 30 Dec 2022 | 29 Dec 2022 | 16 Jan 2023 |
| Income | £0.0000 | 31 Dec 2021 | 30 Dec 2021 | 14 Jan 2022 |
| Income | £0.0000 | 31 Dec 2020 | 30 Dec 2020 | 14 Jan 2021 |
| Income | £0.0000 | 30 Dec 2010 | 23 Dec 2010 | 04 Jan 2011 |
| Income | £0.1140 | 31 Dec 2007 | 28 Dec 2007 | 04 Jan 2008 |
Purchase information
Currency
Base currency:GBP
Fund codes
- Bloomberg:VANGUOG
- Citi:HRG5
- ISIN:IE00B1GHC616
- MEX ID:VIUSOI
- SEDOL:B1GHC61